Xencor (XNCR)
(Delayed Data from NSDQ)
$21.07 USD
-0.13 (-0.61%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $21.07 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 14 |
Average Target Price | $35.08 |
LT Growth Rate | 39.70% |
Industry | Medical - Drugs |
Industry Rank by ABR | 84 of 253 |
Current Quarter EPS Est: | -1.00 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 11 | 11 | 11 | 11 | 11 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/17/2024 | Raymond James | Sean Mccutcheon | Strong Buy | Strong Buy |
9/16/2024 | Piper Sandler | Edward A Tenthoff | Hold | Hold |
9/12/2024 | Cantor Fitzgerald & Co | Pete Stavropoulos | Strong Buy | Strong Buy |
9/9/2024 | Wedbush Securities | David M Nierengarten | Strong Buy | Strong Buy |
8/6/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
6/21/2024 | Canaccord Genuity | John L Newman | Not Available | Strong Buy |
6/14/2024 | BMO Capital Markets | Etzer Darout | Strong Buy | Strong Buy |
6/14/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
5/10/2024 | SVB Securities | Jonathan W Chang | Strong Buy | Strong Buy |
4/16/2024 | BTIG | Kaveri Pohlman | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Tara Bancroft | Strong Buy | Strong Buy |
2/14/2024 | Mizuho SecuritiesUSA | Salim Syed | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.